(Q35582689)

9 August 2017

1 reference

title

Renal dysfunction and acceleration of coronary disease (English)

1 reference

9 August 2017

M W Yerkey

1

1 reference

9 August 2017

S J Kernis

2

1 reference

9 August 2017

B A Franklin

3

1 reference

9 August 2017

K R Sandberg

4

1 reference

9 August 2017

P A McCullough

5

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

90

1 reference

9 August 2017

issue

8

1 reference

9 August 2017

page(s)

961-966

1 reference

Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Cardiorenal risk: an important clinical intersection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Acute myocardial infarction and renal dysfunction: a high-risk combination

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Epidemiology of cardiovascular disease in chronic renal disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768370

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

26 September 2018

1 reference

12 December 2020

Chronic kidney disease as a cardiovascular risk factor

1 reference

12 December 2020

Serum lipoprotein(a) and coronary artery disease in uremic patients on chronic hemodialysis

1 reference

12 December 2020

Chronic renal failure--a vasculopathic state

1 reference

12 December 2020

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.2003.015503

1 reference

9 August 2017

1 reference

9 August 2017

1 reference